Discover B2B companies, suppliers, and manufacturers related to this keyword category
Bringing context to biology and human health through spatial phenotyping — we are The Spatial Biology Company®. 🥼🧬
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics for the treatment of patients
Developing Innovative Cell Therapies Against Cancer
We are in the business of extending life for patients.
This page is no longer active. Please follow us at Labcorp Drug Development.
Leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes.
Founded in 1953, CRI is the world's leading nonprofit dedicated to funding cancer immunotherapy research.
A clinical-stage cancer immunotherapy company and a pioneer in computational target discovery
LEADING THE WAY FROM BASIC TO APPLIED INNOVATIVE RESEARCH
LEADING THE WAY FROM BASIC TO APPLIED INNOVATIVE RESEARCH
We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immunesystem to destroy cancers.
Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c
Harnessing Innate and Adaptive Immune Responses to Cure Disease.
The Eurofins Discovery Products Company
Creating neoantigens by design -- to transform cancer treatments into cures
Improving patient outcomes with AI-powered pathology.
A preclinical-stage biotech focusing on oncology and immunology
Great Science Deserves Great People.
Novel human immunomodulatory proteins for cancer and autoimmune diseases with a specific role in innate immunity
Bringing Effective New Treatments And Options To Patients Who Need Them
A new frontier in the fight against cancer– the right activation of the right immune cells
Smart Clinical Operations. Tailored partnerships. Real results.
Any Assay, Anywhere, Any Area. A Global Leader for Services in Drug R&D Enabling.
Agilex Biolabs is Australia’s Largest and Most Technologically Advanced Biolab with Global Reach
Advancing Immunotherapy with Novel Antigen Discovery
#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation
Targeted delivery of nanoparticles for in vivo CAR T therapy
Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and hematologic cancers
Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.
Pioneering thymus-empowered T-cell platform to fight cancer and infection
From promising to validated immuno-therapeutics: GEM design and humanization, profiling solutions for your candidate
Attacking Bladder Cancer for a Better Tomorrow
We provide drug developers with high-quality data to give them the confidence to take their drug discovery forward.
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
Human translational data early - We help you bridge the safety and dosing gap between pre-clinical & clinical studies
Powering the next generation in bioelectric medicine with Nanosecond Pulsed Field Ablation technology.
At your side to pioneer immuno-oncology therapies
We are developing next-generation antibodies into transformative cancer therapies that improve patients’ lives.
is developing disruptive therapies to address critical unmet medical needs in cancer and infectious diseases.
Accelerating Drug Development with R&D Services Driven by Science and Technology
A fully integrated biotech company at the forefront of pioneering cutting-edge immunotherapies.
Pioneering DARPin Therapeutics for Patients
A leading Immuno Oncology company in the space of NK cell therapeutics
Unlocking targeted medicines with our transformative mRNA platform
We are in the business of extending life for patients.
Engineering the future of targeting Natural Killer off-the-shelf cell therapy against cancer.
Developing Biotechnology Solutions That Transforms Lives | Clinical Research | Bioanalytical & Drug Development
"Turn breakthroughs into success with Snow Leopard Consulting's innovative, cost-effective preclinical solutions." ©️
An off-the-shelf multimodal biological immunotherapy company empowering the patient's immune system to fight cancer.
ImmuNext develops compounds on the cutting edge of immunotherapy for cancer and autoimmune diseases.
Harnessing the Power of Natural Killer Cells
Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the course of disease
A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases.
We transform lives by inspiring science & leading innovation.
Discover the Hidden Variables that Predict Patient Response
We understand disease through the lens of the immune system for more effective, safer treatments & better diagnosis.
Altevax is developing a disruptive immunotherapy technology against cancer
Clinical-stage biotech company developing drugs that harness glyco-immunology to treat cancer and inflammatory diseases
Committed to delivering effective TCR cancer therapies. Striving towards a cure.
Deep Immune Phenotyping & MultiOmics DataScience, for immune precision medicine
A specialty oncology CRO and a pioneer in immunotherapy studies.
Your partner in immunology projects!
The KREX™ platform delivers precision antibody profiling with correctly folded, highly multiplexed proteins.
MAKING THE INVISIBLE VISIBLE IN THE FIGHT AGAINST CANCER
TiumBio is committed to developing innovative therapeutics for patients with rare or incurable diseases
An advanced-clinical-stage biotechnology company developing dendritic cell therapies to treat cancer
On a quest to leverage the power of single cell genomics to discover novel drug targets and precision therapeutics.
Visibility to Immuno-Oncology & Lymphocyte Enhancing Therapies
Developing transformative medicines in neuroscience using artificial intelligence approaches
Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease
Maximizing immune integrity through the development of unique natural killer (NK) cell therapies.